Skip to main content
OpenTrials

Clinical trial condition

Constipation

Explore clinical trials studying Constipation. Study availability and eligibility vary by location and protocol.

47 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Constipation trial results

Completed

Safety of Subcutaneous Methylnaltrexone for Opioid-Induced Constipation in Patients With Advanced Illness

NCT00672139

Conditions
Chemically-Induced Disorders, Constipation, Mental Disorders, +7 more
Locations
  • Salix Investigational Site Mobile, Alabama, United States
  • Salix Investigational Site Laguna Hills, California, United States
  • Salix Investigational Site Lancaster, California, United States
  • Salix Investigational Site Aurora, Colorado, United States
View all 46 locations
View Trial Details
Completed

A Study of Naldemedine (S-297995) for the Treatment of Opioid-Induced Constipation in Adults With Non-Malignant Chronic Pain Receiving Opioid Therapy

NCT01443403

Conditions
Chemically-Induced Disorders, Constipation, Mental Disorders, +7 more
Locations
  • Shionogi Research Site Phoenix, Arizona, United States
  • Shionogi Research Site Sun Lakes, Arizona, United States
  • Shionogi Research Site Little Rock, Arkansas, United States
  • Shionogi Research Site Anaheim, California, United States
View all 49 locations
View Trial Details
Completed

Efficacy and Safety of Naldemedine in Treating Opioid-induced Constipation

NCT01993940

Conditions
Chemically-Induced Disorders, Constipation, Mental Disorders, +7 more
Locations
  • Shionogi Research Site Birmingham, Alabama, United States
  • Shionogi Research Site Homewood, Alabama, United States
  • Shionogi Research Site Goodyear, Arizona, United States
  • Shionogi Research Site Little Rock, Arkansas, United States
View all 49 locations
View Trial Details
Completed

Efficacy and Safety of Naldemedine in the Treatment of Opioid-induced Constipation

NCT01965158

Conditions
Chemically-Induced Disorders, Constipation, Mental Disorders, +7 more
Locations
  • Shionogi Research Site Birmingham, Alabama, United States
  • Shionogi Research Site Phoenix, Arizona, United States
  • Shionogi Research Site Fresno, California, United States
  • Shionogi Research Site Long Beach, California, United States
View all 65 locations
View Trial Details
Completed

A 12-week Extension of the Phase III Study (D3820C00004) to Assess the Effect and Safety of NKTR-118 in Patients With Non-cancer-related Pain and Opioid-induced Constipation

NCT01395524

Conditions
Chemically-Induced Disorders, Constipation, Mental Disorders, +7 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Calera, Alabama, United States
  • Research Site Glendale, Arizona, United States
  • Research Site Mesa, Arizona, United States
View all 116 locations
View Trial Details
Completed

Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation

NCT01323790

Conditions
Chemically-Induced Disorders, Constipation, Mental Disorders, +7 more
Locations
  • Research Site Mobile, Alabama, United States
  • Research Site Pell City, Alabama, United States
  • Research Site Mesa, Arizona, United States
  • Research Site Phoenix, Arizona, United States
View all 120 locations
View Trial Details
Completed

Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation

NCT01309841

Conditions
Chemically-Induced Disorders, Constipation, Mental Disorders, +7 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Calera, Alabama, United States
  • Research Site Glendale, Arizona, United States
  • Research Site Mesa, Arizona, United States
View all 117 locations
View Trial Details

Related conditions